Clinical Trials Browser

Endometrial Adenocarcinoma × Nivolumab × 1 year × Clear all

NCT04106414 2025-10-14

Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment

Phase 2 Active not recruiting

GynecologicSarcoma

Endometrial Adenocarcinoma